Abnova produce y desarrolla mas de 19.000 proteínas recombinantes, mas de 12.000 anticuerpos MaxPab, mas de 16.000 anticuerpos monoclonales y mas de 20.000 anticuerpos policlonales dirigidos al genoma humano.
Anti-Risankizumab (Human) ELISA Kit (Qualitative)
Anti-Risankizumab (Human) ELISA Kit (Quantitative)
Anti-Secukinumab (Human) ELISA Kit (Qualitative)
Anti-Tocilizumab (Human) ELISA Kit (Qualitative)
Anti-Tocilizumab (Human) ELISA Kit (Quantitative)
Anti-Trastuzumab (Human) ELISA Kit (Qualitative)